Fuji Health Science Announces Name Change


Fuji Health Science, Inc. recently announced that as of September 1, 2016, the
name of the entity has become Fuji Chemical Industries USA, Inc. to align fully in identity and mission with its parent company, Fuji Chemical Industries Co., Ltd., a worldwide leader in pharmaceutical ingredients and biotechnology.

“As we celebrate our 70th anniversary of Fuji Chemical Industries Co., Ltd., this name change allows us to present ourselves in alignment with the global Fuji Chemical Industries Group, a leader in pharmaceutical ingredients and spray dry technology with an exceptional track record of innovation and superior quality. The name change also enables us to expand on our basic business to begin aggressively marketing contract manufacturing services in addition to excipients,” said Charles DePrince, President of Fuji Health Science, Inc.

The company continues to operate customarily in its current structure. However, the email addresses have changed to “@fujichemicalusa.com” and its homepage has become www.fujichemicalusa.com to reflect and strengthen its corporate identity.

Fuji Chemical Industries Co., Ltd. is engaged in the production and sale of pharmaceutical products/synthesis, the manufacture of pharmaceutical and bulk pharmaceutical products, and the production and sale of food additives. It offers contract manufacturing services that include API manufacturing; functional APIs, such as drug intermediates; and drug products manufacturing. The company also provides excipients and drug delivery systems.

BOOST VACCINATION DATA ENCOURAGE CONTINUED DEVELOPMENT OF AFFiRiS THERAPEUTIC PARKINSON’S DISEASE VACCINE AGAINST ALPHA-SYNUCLEIN